Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04234659 · ClinicalTrials.gov registry record
PPCM Observational Study (Peripartum Cardiomyopathy)
A clinical trial of Cardiogenic Shock and Peripartum Cardiomyopathy, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT04234659 is a study of Cardiogenic Shock and Peripartum Cardiomyopathy that has completed, run by Medical College of Wisconsin. The registered enrollment target is 150 participants, below the 625-participant average among 16 other Cardiogenic Shock trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04234659, a study of Cardiogenic Shock and Peripartum Cardiomyopathy, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the clinical treatment of patients diagnosed with peripartum cardiomyopathy complicated by cardiogenic shock.
Conditions Studied
Interventions
- DEVICE Clinical placement of a temporary IMPELLA® mechanical circulatory support device.
Study Locations (1)
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-01-11 |
| Est. Completion | 2025-08-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04234659
The ClinicalTrials.gov registry entry for NCT04234659 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 625-participant average among 16 other Cardiogenic Shock trials with a reported enrollment target (76% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiogenic Shock appearing as the primary indexed condition, and to 1 intervention - of which Clinical placement of a temporary IMPELLA® mechanical circulatory support device. is the first listed.
NCT04234659 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04234659 about?
NCT04234659 is a clinical study titled "PPCM Observational Study (Peripartum Cardiomyopathy)". The purpose of this study is to examine the clinical treatment of patients diagnosed with peripartum cardiomyopathy complicated by cardiogenic shock.
What is the current status of trial NCT04234659?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2021-01-11. Estimated completion is 2025-08-05.
What conditions does trial NCT04234659 study?
This clinical trial studies the following conditions: Cardiogenic Shock, Peripartum Cardiomyopathy.
What interventions are being tested in trial NCT04234659?
The interventions under investigation include: Clinical placement of a temporary IMPELLA® mechanical circulatory support device. (DEVICE).
Who is sponsoring clinical trial NCT04234659?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04234659 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiogenic Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Cardiac Power Output in Cardiogenic Shock Patients
RECRUITING · Early Phase 1
-
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
RECRUITING
-
Inova Cardiogenic Shock Registry (INOVA SHOCK)
RECRUITING
-
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
RECRUITING
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.